February 17, 2022
Given the global economic recessions mediated by the COVID-19 pandemic and that many countries have implemented direct income support programs, we investigated the timing of the COVID-19 economic impact payments and opioid overdose deaths.
December 28, 2021
Structural racism, including lack of access to substance use treatment and discrimination in the criminal justice system, is resulting in a deadly rise in overdoses among people of color. A government study seeks effective interventions.
April 20, 2020
Effects of the Ohio Opioid Prescribing Guidelines on Total Joint Arthroplasty Postsurgical Prescribing and Refilling Behavior of Surgeons and Patients
In 2017, Ohio guidelines were passed to reduce acute pain opioid prescriptions. We compared pre/post-guidelines opioid scripts for hip and knee arthroplasty.
March 19, 2020
Researchers found that white males ages 30 to 39 were most at risk of fatal overdoses in Ohio. The study also identified 12 clusters in the state where overdose rates were highest.
December 9, 2019
AMES, Iowa - The United States is suffering from several different simultaneous opioid epidemics, rather than just a single crisis, according to an academic study of deaths caused by drug overdoses.
November 12, 2019
Opioid misuse and deaths are increasing in the United States. In 2017, Ohio had the second highest overdose rates in the US, with the city of Cincinnati experiencing a 50% rise in opioid overdoses since 2015.
March 26, 2019
Federal money to fight the opioid crisis nearly doubled in the last two years, according to a national think tank’s new report analyzing that funding.
March 12, 2019
To address the growing misuse and diversion of prescription drugs, the Ohio General Assembly adopted legislation in 2004 authorizing the State of Ohio Board of Pharmacy to create a Prescription Monitoring Program (PMP), known as the Ohio Automated Rx Reporting System (OARRS). Established in 2006, OARRS collects information on all outpatient prescriptions for controlled substances and two non-controlled substances (gabapentin and naltrexone) dispensed by Ohiolicensed pharmacies and personally furnished by Ohio prescribers. This data is reported every 24 hours and is maintained in a secure database. Drug wholesalers and manufacturers are also required to submit information monthly on all controlled substances and gabapentin sold to an Ohio licensed pharmacy or prescriber.